J Cancer 2024; 15(3):590-602. doi:10.7150/jca.86283 This issue Cite

Research Paper

LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer

Cagri Cakici1✉, Benay Daylan2, Ruveyde Safiye Unluer3, Ebru Emekli-Alturfan4, Sule Ayla5, Hilal Eren Gozel6, Pakize Yigit7, Elif Yavuz Dokgoz8, Turkan Yigitbasi1

1. Department of Biochemistry, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey, 34815.
2. Department of Histology and Embryology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey, 34815.
3. Graduate School of Health Sciences, Istanbul Medipol University, Istanbul, Turkey, 34815.
4. Department of Basic Medical Sciences, Faculty of Dentistry, Marmara University, Istanbul, Turkey, 34857.
5. Department of Histology and Embryology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey, 34720.
6. Department of Medical Biology and Genetics, Faculty of Medicine, Istanbul Okan University, Istanbul, Turkey, 34959.
7. Department of Biostatistics and Medical Informatics, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey, 34815.
8. Department of Biochemistry, Faculty of Pharmacy, Istinye University, Istanbul, Turkey, 34010.

Citation:
Cakici C, Daylan B, Unluer RS, Emekli-Alturfan E, Ayla S, Gozel HE, Yigit P, Dokgoz EY, Yigitbasi T. LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. J Cancer 2024; 15(3):590-602. doi:10.7150/jca.86283. https://www.jcancer.org/v15p0590.htm
Other styles

File import instruction

Abstract

Graphic abstract

Increased LDH-A activity promotes tumor growth, migration, invasion, and metastasis. This study aimed to investigate the effects of the combination of LDH-A inhibitor and Docetaxel on apoptosis and epithelial-mesenchymal transition (EMT) in the murine prostate cancer (PCa) model.

The prostate cancer murine model was developed subcutaneously in 50 male B57CL/6 mice using the Tramp-C2 prostate cancer cell line. From the tumor tissue samples, apoptosis analysis was performed using TUNEL staining, and EMT was investigated using western blot and qPCR. Hematoxylin-eosin staining (HE) and Periodic acid-Schiff staining were used to histopathologically examine liver and kidney tissues.

Lactate levels revealed that the Warburg effect was reversed with the LDH-A inhibitor. Both serum and tumor tissue apoptosis increased, and tumor sizes reduced in PCa+LDH-A inhibitor + Docetaxel treatment groups (p<0.05). The combination of LDH-A inhibitor and Docetaxel inhibited EMT mechanism by causing a decrease in Snail, Slug, Twist, and HIF-1α expressions as well as a decrease in N-cadherin and an increase in E-cadherin levels.

Reprogramming glucose metabolism with an LDH-A inhibitor can increase the effectiveness of Docetaxel on apoptosis and metastasis mechanisms in PCa.

Keywords: Prostate cancer, Apoptosis, EMT, LDH-A inhibitor, Warburg effect


Citation styles

APA
Cakici, C., Daylan, B., Unluer, R.S., Emekli-Alturfan, E., Ayla, S., Gozel, H.E., Yigit, P., Dokgoz, E.Y., Yigitbasi, T. (2024). LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. Journal of Cancer, 15(3), 590-602. https://doi.org/10.7150/jca.86283.

ACS
Cakici, C.; Daylan, B.; Unluer, R.S.; Emekli-Alturfan, E.; Ayla, S.; Gozel, H.E.; Yigit, P.; Dokgoz, E.Y.; Yigitbasi, T. LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. J. Cancer 2024, 15 (3), 590-602. DOI: 10.7150/jca.86283.

NLM
Cakici C, Daylan B, Unluer RS, Emekli-Alturfan E, Ayla S, Gozel HE, Yigit P, Dokgoz EY, Yigitbasi T. LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. J Cancer 2024; 15(3):590-602. doi:10.7150/jca.86283. https://www.jcancer.org/v15p0590.htm

CSE
Cakici C, Daylan B, Unluer RS, Emekli-Alturfan E, Ayla S, Gozel HE, Yigit P, Dokgoz EY, Yigitbasi T. 2024. LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. J Cancer. 15(3):590-602.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image